News | August 28, 2013

VuComp M-Vu CAD System for Mammography Installed at Cancer Center in Richmond, Va.

August 28, 2013 — VuComp Inc. announced it has installed its advanced computer-aided detection (CAD) system, M-Vu CAD, at Allison Breast Center in Richmond, Va. The VuComp system, the first of its kind in Virginia, will analyze images from the clinic’s new Philips MicroDose Mammography system. Women in the region will have access to the world’s most advanced tools to help detect breast cancer as early as possible in order to achieve the best outcomes. VuComp’s M-Vu system analyzes mammographic images and marks suspicious areas using sophisticated mathematical algorithms.

“Our experience with VuComp’s CAD system has been extremely satisfactory in that it does not overcall and certainly is very sensitive to real abnormalities,” said Michael Bigg, M.D., JD, chief radiologist and owner of Allison Breast Center. “Earlier CAD systems with older software technology, which are still widely in use, certainly flag far too many abnormalities, reducing diagnostic confidence and wasting time.”

Bigg noted that VuComp CAD has also been an important aid in helping patients understand their situation — and in gaining their confidence. “Surprisingly, not all patients when shown an abnormality on a mammogram are comfortable with proceeding to an immediate biopsy, especially when these are small and more subtle. I spend a lot of time convincing reluctant patients of the need for biopsy. I’ve found that when I point out VuComp’s CAD marks on their mammogram it helps them to understand and become more comfortable with the recommendation.”

The VuComp system received U.S. Food and Drug Administration (FDA) approval to work with film mammography systems in January 2012, and a supplementary approval for digital mammography in October 2012. While CAD systems have been used in clinical practice since the mid-1990s, recent FDA guidelines have significantly raised the bar for CAD performance and now recommend comprehensive reader studies proving that radiologists are more effective when they use CAD. The VuComp system is the only FDA-approved mammography CAD product that meets these recommendations.

For more information: www.vucomp.com

Related Content

Fujifilm Installing New DR Equipment for Three Large Healthcare Systems
News | Digital Radiography (DR) | September 22, 2017
Fujifilm Medical Systems U.S.A. Inc. recently closed new contracts to enhance diagnostic imaging capabilities for...
Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Matrix Analytics Beginning Validation of Deep Learning Lung CT Tools
News | Lung Cancer | September 13, 2017
Matrix Analytics announced it will clinically validate its LungDirect deep learning and predictive analytics tools for...
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Breast imaging X-ray mammogram showing a breast tumor. Photo courtesy of Monthian Ritchan-Ad

Photo courtesy of Monthian Ritchan-Ad

Feature | Breast Density | September 08, 2017 | By Roy Prager, M.D.
While mammograms play a vital role in efforts to identify breast cancer, they can present some challenges in women with...
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
FDA Releases Six-Month Inspection Data From EQUIP Mammography Quality Initiative
News | Mammography | September 01, 2017
September 1, 2017 — The Division of Mammography Quality Standards (DMQS) of the U.S.
Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
Overlay Init